INSIGHTS ON DRUG DEVELOPMENT

• IP Considerations In Drug Development For Biotech Companies

  Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.

• Ask Us Anything: Hannah McLachlan on Crystallization In Peptide Development

  Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.

• Why Biopharma Breakthroughs Aren't Moving The Market

  Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.

• Optimization And Scale-Up Of A Plasmid DNA Production Process

  Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.

• Characterization Of Pharmaceutical Materials With Modulated DSC

  12/30/2024

  Modulated DSC addresses challenges in pharmaceutical material characterization, enabling precise analysis of glass transitions, and overlapping transitions, enhancing insights beyond standard DSC.

• Understanding Adeno-Associated Virus Vector Impurities

  11/13/2025

  AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.

• Non Animal Origin Squalene For High-Risk Applications

  7/21/2025

  Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.

• Drug Development Plan Explained: DPP Templates And Examples

  7/27/2026

  Only 6.7% of Phase 1 drugs reach approval. A well-structured Drug Development Plan (DDP) can meaningfully improve your odds — learn exactly how to build one.

• Robust Database Characterizes And Optimizes Product Development

  8/29/2026

  Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.